Lithium stocks that will make it?

Originally posted by micky78 ↑

Thanks Billyen

Don't forget right now GLN has news and drill results that's why there are liquidity more than BMG. Once BMG gets good drill results there will be more volume (eg easily 30 million shares traded a day). Most of GLN options are issued to directors and they won't able to sell to provide liquidity.

Once BMG gets to above 2c on good drill results there are 350 million options to exercise. This will add $7m cash and liquidity. They only spend a little bit over $1 million a year (drill and admin fee, most directors are on low salary of $40k and one on $180k). It will take 6 years to spend that exercised option money.

As regard to the race between GLN and BMG, BMG is actually disadvantaged as it has more options, more shares to move and more liquidity than GLN. But even include all options, at 3.5c it is still a $30m company with $7m cash from options. Even if you pay 1c now, at 3.5c you can still triple your money and probably won't take a year.

For me I always focus on % of return. I've done exceptional well in the last 10 years. Most of stock I invested in the past have done over 5 folds. I don't fall in love with a stock. I look for % of return. If you can do 3 to 5 folds each year with large investment money, you do extremely well.

GLN is a good stock. But if you look at GLN chart, it clearly over priced at 60s. From company directors point of view they are focus on good assets as they cannot sell their shares. From investors point of view we are focus on % of return as we can sell shares and there are other opportunities like BMG right now.

I've done well on COB (from less than 20c to over $1). Do I fall in love with COB? No, I got what I want and sold at near the top. At that time several cobalt stocks already gone up. I saw my opportunity with COB.

It is a number game (Money Ball). I remember watching the movie Money Ball. It is so true with stock market too. If you want the best players in the league you need to pay $20 million each. You can draft an unknown player and only pay peanuts ($500k). He can still get on base for you (most cost effective). Brett Pit said to Jonah Hill "do I care how he got on base? No, he gets on base more often than top players". Does top player worth 40 times more than unknown player who get on base just as often? You may not win a championship but as the owner of the club you make big dollar in your pocket by picking up bargains. Stock market is like this. There is no point telling me how great a company is if you are paying top dollars.

just IMHO, do your own research

Expand

Wow...
I don't even have the words.

BTH

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

GRL

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

AUN

Cyclone signs MOU with Vale for development of Iron Bear play

AN1

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

EDE

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

LYN

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

BNL

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

HotCopper Highlights: Your most watched stocks for Week 46, 2024

ME1

Wow... I don't even have the words.

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

Cyclone signs MOU with Vale for development of Iron Bear play

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

HotCopper Highlights: Your most watched stocks for Week 46, 2024

Banshee's historic trenches prove rich in antimony and gold for GDM

Wow... I don't even have the words.

Top Stories

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

Cyclone signs MOU with Vale for development of Iron Bear play

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

HotCopper Highlights: Your most watched stocks for Week 46, 2024

Banshee's historic trenches prove rich in antimony and gold for GDM